Cargando…
Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study
INTRODUCTION: 30 day mortality in patients with Acute Respiratory Failure (ARF) is approximately 30%, defined as patients requiring ventilator support for more than 6 hours. Novel biomarkers are needed to predict patient outcomes and to guide potential future therapies. The activins A and B, members...
Autores principales: | de Kretser, David Morritz, Bensley, Jonathan Guy, Pettilä, Ville, Linko, Rita, Hedger, Mark Peter, Hayward, Susan, Allan, Carolyn Anne, McLachlan, Robert Ian, Ludlow, Helen, Phillips, David James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057391/ https://www.ncbi.nlm.nih.gov/pubmed/24172607 http://dx.doi.org/10.1186/cc13093 |
Ejemplares similares
-
Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection
por: Linko, Rita, et al.
Publicado: (2014) -
Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation
por: de Kretser, David M., et al.
Publicado: (2016) -
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
por: Lidbury, Brett A., et al.
Publicado: (2017) -
Testicular activin and follistatin levels are elevated during the course of experimental autoimmune epididymo–orchitis in mice
por: Nicolas, Nour, et al.
Publicado: (2017) -
Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)